OMRON Stock 6645.T
OMRON stock (6645.T): Quarterly and annual results since 2024 from Quarterly Report and EDINET filings: revenue, earnings, balance sheet, cash flow and management guidance, every figure with its source. As of 08/2026, quarterly reporting. Stock analysis by NadirAlpha. OMRON stock (6645.T): listed on JPX, index Nikkei 225. NadirAlpha has evaluated 11 original documents, cross-checked every figure automatically and linked each to its source; sources as of 08/2026. Revenue Q1 FY2027 (Apr to Jun 2026): JPY 209.9 billion (+26% year on year). Latest reading: Operating income doubled, Cash flow inflection, Guidance raised, Divestiture, Strategic pivot.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
OMRON Current Status
Summary of the most recent reporting period of OMRON (Q1 FY2027): core figures, drivers and management statements, every figure with a source number. NadirAlpha methodology
Assessment by NadirAlpha, as of Q1 FY2027 (Apr to Jun 2026).
OMRON Stock: Key Figures (¥ million)
The core financial figures of OMRON stock in three views: fiscal years up to FY2027, half-years and quarters up to Q1 FY2027, in ¥ million, most recent period first. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Calendar quarter | Revenue | Net income | EPS (¥) | OCF | Source |
|---|---|---|---|---|---|---|
| FY2026 | Q2/2025–Q1/2026 | 767,351 | 28,487~ | 144.8 | 60,919 | 10 |
| FY2025 | Q2/2024–Q1/2025 | 715,379 | 16,271 | 82.63 | 55,784 | 110 |
| FY2024 | Q2/2023–Q1/2024 | 818,761 | 8,105 | 41.17 | 44,875 | 6 |
Half-years
| Period | Calendar quarter | Published | Revenue | Net income | EPS (¥) | FCF | Cash | Net Debt | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-H2* | Q4/2025–Q1/2026 | 2026-06-22 | 373,903 | 19,440 | 98.81*≈ | 2,864 | 166,603 | 30,975 | 10 |
| 2026-H1* | Q2–Q3/2025 | 2025-11-14 | 393,448 | 9,047 | 45.96 | 4,950 | 160,595 | – | 109 |
| 2025-H2* | Q4/2024–Q1/2025 | 2025-06-23 | 427,115 | 19,589 | 99.48*≈ | 5,126 | 149,023~ | -9,563~ | 8 |
| 2025-H1* | Q2–Q3/2024 | 2024-11-14 | 374,638 | -3,318 | -16.86 | 1,665 | 161,338 | -10,421 | 109 |
| 2024-H2* | Q4/2023–Q1/2024 | 2024-06-21 | 418,087 | 2,025 | 10.29*≈ | -7,415 | 143,086 | -22,012 | 6 |
| 2024-H1* | Q2–Q3/2023 | 2023-11-14 | 400,674 | 6,080 | 30.89 | 6,912 | 107,715 | – | 107 |
Quarters
| Period | Calendar quarter | Published | Revenue | Op. income | Net income | EPS (¥) | FCF | Cash | Net Debt | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2027-Q1* | Q2/2026 | 2026-08-05 | 209,864 | 18,857 | 10,635 | 54.08≈ | 57,343 | 217,868 | 11,597 | 111 |
| 2026-Q2* | Q3/2025 | 2025-11-14 | 226,968 | – | 4,446 | 22.59*≈ | -6,667 | 160,595 | – | 9 |
| 2026-Q1* | Q2/2025 | 2026-08-05 | 166,480 | 5,784 | 4,601~ | 23.37≈ | 11,617 | 156,914 | – | 111 |
| 2024-Q4* | Q1/2024 | 2024-06-21 | 210,776 | – | 256 | 1.30*≈ | -1,576 | 143,086 | -22,012 | 6 |
| 2024-Q3* | Q4/2023 | 2024-02-14 | 207,311~ | – | 1,769~ | 8.98 | -5,839 | 129,311 | – | 5 |
| 2024-Q2* | Q3/2023 | 2023-11-14 | 197,323 | – | -7,316 | -37.16 | 8,273 | 107,715 | – | 4 |
| 2024-Q1* | Q2/2023 | 2023-08-09 | 203,351 | – | 13,396 | 68.05 | -1,361 | 97,711 | – | 103 |
OMRON Balance Sheet & Cash Flow (¥ million)
Balance sheet and cash flow of OMRON up to Q1 FY2027 in ¥ million: net debt = financial debt minus cash, free cash flow = operating cash flow minus capex, every input sourced. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
Fiscal years
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q2/2025–Q1/2026 | 2026-06-22 | 166,603 | 197,578 | 30,975 | 33,778 | 60,919 | 53,105 | 7,814 | 10 |
| FY2025 | Q2/2024–Q1/2025 | 2025-06-23 | 149,023~ | 139,460 | -9,563~ | 33,450 | 55,784 | 48,993~ | 6,791~ | 110 |
| FY2024 | Q2/2023–Q1/2024 | 2024-06-21 | 143,086 | 121,074° | -22,012 | 30,816 | 44,875 | 45,378 | -503 | 6 |
Half-years
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-H2 | Q4/2025–Q1/2026 | 2026-06-22 | 166,603 | 197,578 | 30,975 | 17,279 | 32,933 | 30,069 | 2,864 | 10 |
| 2026-H1 | Q2–Q3/2025 | 2025-11-14 | 160,595 | – | – | 16,499 | 27,986 | 23,036 | 4,950 | 109 |
| 2025-H2 | Q4/2024–Q1/2025 | 2025-06-23 | 149,023~ | 139,460 | -9,563~ | 16,624 | 31,939 | 26,813 | 5,126 | 8 |
| 2025-H1 | Q2–Q3/2024 | 2024-11-14 | 161,338 | 150,917 | -10,421 | 16,826 | 23,845 | 22,180 | 1,665 | 109 |
| 2024-H2 | Q4/2023–Q1/2024 | 2024-06-21 | 143,086 | 121,074° | -22,012 | 16,981 | 19,143 | 26,558 | -7,415 | 6 |
| 2024-H1 | Q2–Q3/2023 | 2023-11-14 | 107,715 | – | – | 13,835 | 25,732 | 18,820 | 6,912 | 107 |
Quarters
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2027-Q1 | Q2/2026 | 2026-08-05 | 217,868 | 229,465 | 11,597 | 11,017 | 63,969 | 6,626 | 57,343 | 111 |
| 2026-Q4 | Q1/2026 | 2026-06-22 | 166,603 | 197,578 | 30,975 | – | – | – | – | 10 |
| 2026-Q2 | Q3/2025 | 2026-08-05 | 160,595 | – | – | 4,958 | 11,539 | 18,206 | -6,667 | 11 |
| 2026-Q1 | Q2/2025 | 2026-08-05 | 156,914 | – | – | 11,541 | 16,447 | 4,830 | 11,617 | 111 |
| 2025-Q4 | Q1/2025 | 2025-06-23 | 149,023 | 139,460 | -9,563 | – | – | – | – | 8 |
| 2025-Q2 | Q3/2024 | 2024-11-14 | 161,338 | 150,917 | -10,421 | – | – | – | – | 7 |
| 2024-Q4 | Q1/2024 | 2024-06-21 | 143,086 | 121,074° | -22,012 | 8,527 | 13,024 | 14,600 | -1,576 | 6 |
| 2024-Q3 | Q4/2023 | 2024-02-14 | 129,311 | – | – | 8,454 | 6,119 | 11,958 | -5,839 | 5 |
| 2024-Q2 | Q3/2023 | 2023-11-14 | 107,715 | – | – | 6,938 | 17,878 | 9,605 | 8,273 | 4 |
| 2024-Q1 | Q2/2023 | 2023-08-09 | 97,711 | – | – | 6,897 | 7,854 | 9,215 | -1,361 | 103 |
OMRON Guidance Tracking (latest per metric/period · 8/11)
NadirAlpha records 11 guidance statements of OMRON neutrally: annual and quarterly targets, direction of change and outcome as a dot with legend, with no estimate of our own. NadirAlpha methodology
Actuals: revenue in ¥m
Direction: initiatedraised Verdict: misspending
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2030 | 2026-06-22 | EPS (GAAP) | 20% | – | 10 | ||
| FY2030 | 2026-06-22 | Revenue growth (YoY) | 7% | – | – | 10 | |
| FY2030 | 2026-06-22 | Operating Income | 12% | – | 10 | ||
| FY2030 | 2026-06-22 | ROE | 10–12% | – | 10 | ||
| FY2030 | 2026-06-22 | ROIC | 8–10% | – | 10 | ||
| FY2027 | 2026-08-05 | Revenue | 880,000 | – | 11 | ||
| FY2027 | 2026-08-05 | EBIT | 80,000 | – | 11 | ||
| FY2027 | 2026-08-05 | Profit Before Tax | 79,000 | – | 11 | ||
| FY2024 | 2024-06-21 ° | Revenue | 825,000 | 818,761 | 6 | ||
| FY2024 | 2024-06-21 ° | Gross margin (GAAP) | 44.7% | – | – | 6 | |
| FY2024 | 2024-06-21 ° | Operating Income | 49,000 | – | – | 6 |
OMRON Stock: Price & Chart
Chart and key figure trend of OMRON stock: the TradingView chart starts only on click, the key figure chart comes from the core tables up to Q1 FY2027. NadirAlpha methodology
No embedded chart is licensed for this exchange; the chart opens on TradingView in a new tab.
OMRON Event Timeline
NadirAlpha sorts 37 events of OMRON by quarter, most recent first, each with source number and event type, management quotes as direct quotes at the start of the quarter. NadirAlpha methodology
2027 · 8 events
Q1 operating income JPY 18,857 million rose 226.0% YoY and revenue JPY 209,864 million rose 26.1% YoY, led by AI semiconductor and data center demand in the Control Devices segment 11
Full-year consolidated forecast for revenue, operating income, and pre-tax income revised upward 11
Operating income more than doubled YoY (5,784.0 to JPY 18,857.0 million, +226%). 111
Operating cash flow reached JPY 63,969.0 million vs JPY 16,447.0 million in 2026-Q1 (×3.9). 111
Device & Module Solutions (electronic components) business to be divested to Carlyle Group, effective October 1, 2026 11
FY2026 net income reached 28,487 million yen (+75.1% year-over-year), recovering from a prior-year net loss of approximately 37,109 million yen that was driven by NEXT2025 restructuring charges and asset impairments 10
Device & Module Solutions Business (Electronic Components Business, DMB) classified as discontinued operations; following absorption-type split on March 30, 2026, transfer to The Carlyle Group is planned for October 1, 2026 10
SF 2nd Stage strategic plan launched (FY2026-FY2030), targeting GEMBA DX transformation with focused investment in eight device businesses and five data service businesses, and cumulative cash generation of 1,050 billion yen over five years 10
2026 · 7 events
DSB (Data Solution Business) revenue grew +19.7% to JPY 51,151.0 million in FY2026 (87% of group revenue) while group revenue changed -92.9%. 10
H1 consolidated revenue rose 5.0% year-over-year to 393,448 million yen, with Industrial Automation (Control Components Business) up 8.2% on recovering semiconductor-related demand and Electronic Components (Electronic Components Business) up 10.8% on AI-driven semiconductor demand 9
H1 operating profit fell 7.8% year-over-year despite revenue growth, weighed by 5,827 million yen in structural reform costs (primarily non-cash asset impairments and disposals under NEXT2025) and an 8.0% revenue decline in Healthcare (Healthcare Business) due to continued China consumer weakness 9
Agreement signed July 4, 2025 to transfer all shares of OMRON AUTOMOTIVE ELECTRONICS ITALY S.R.L to Fair Cap; completion targeted by end of November 2025 9
Full-year net income attributable to shareholders recovered to 16,271 million JPY from 8,105 million JPY in the prior year, despite 27,781 million JPY in total NEXT2025 restructuring charges and 11,725 million JPY goodwill impairment on the Data Solutions Business segment due to JMDC share price decline (8)
Free cash flow turned positive at approximately 7,900 million JPY, an improvement of 70,100 million JPY versus the prior year; operating cash flow rose to 55,784 million JPY from 44,875 million JPY (8)
JMDC and 35 subsidiaries fully consolidated into the new Data Solutions Business segment following a tender offer for approximately 23.0% of JMDC voting shares; goodwill impairment of 11,725 million JPY recorded on the segment due to JMDC share price decline (8)
2025 · 7 events
Net income more than doubled YoY (8,105.0 to JPY 16,271.0 million, +101%). 8
H1 net income attributable to shareholders swung to -3,318 million JPY from +6,080 million JPY in the prior-year period, driven by 21,366 million JPY in NEXT2025 restructuring charges for workforce optimization (7)
H1 revenue declined 6.5% YoY to 374,638 million JPY, with Industrial Automation Business down 17.1% and Device & Module Business down 16.5% on weak control device demand (7)
NEXT2025 structural reform launched with 21,366 million JPY in H1 charges covering workforce and capacity optimization; Data Solutions Business established as a new reporting segment via JMDC consolidation (7)
Full-year net income fell to JPY 8,105M (EPS: JPY 41.17) from JPY 73,861M (EPS: JPY 372.19) in the prior year; full-year revenue declined to JPY 818,761M from JPY 876,082M, with IAB and ECB the primary drivers of the decrease 6
FY2025 guidance issued: revenue JPY 825.0B (+0.8% YoY), operating profit JPY 49.0B (+42.7% YoY) 6
NEXT2025 structural reform program announced February 2024, targeting approximately 2,000 global headcount reductions with approximately JPY 28.0B in one-time costs; medium-term plan 'SF 1st Stage' withdrawn; 'SF 2nd Stage' scheduled for FY2026 to 2030 6
2024 · 15 events
Net income more than halved YoY (73,861.0 to JPY 8,105.0 million, -89%). 6
Net income more than halved YoY (23,344.0 to JPY 256.0 million, -99%). 6
Operating profit -63.5% YoY; net income -84.5% YoY including JPY 12.0B JMDC equity revaluation loss; IAB demand weakness and lower gross margin were primary drivers 5
Revenue -4.7% YoY as Industrial Automation Business continued to face capex demand weakness and inventory adjustment; Healthcare Business +9.3% and Social Systems Business +41.4% partially offset the decline 5
JMDC and its 35 subsidiaries fully consolidated (group expanded from 117 to 156 entities); Data Solutions Business (DSB) added as fifth operating segment; CancerScan acquired at 100% on January 26, 2024 5
Operating cash flow reached JPY 6,119.0 million vs JPY 1,188.0 million in 2023-Q3 (×5.2). 5
Net income fell 78.2% YoY including JPY 10.2B equity revaluation loss on JMDC shares recognized upon consolidation; operating profit -50.4% YoY on IAB demand weakness and higher manufacturing and personnel costs 4
Revenue -0.9% YoY as IAB capex demand weakness and inventory adjustment reduced sales; Electronic Components Business declined 5.8% YoY 4
Omron acquired approximately 23.0% of JMDC shares via tender offer and consolidated JMDC as a subsidiary on October 16, 2023, reaching approximately 54.3% voting rights 4
Net income +68.0% YoY to JPY 13.4B and operating profit +19.9% YoY to JPY 14.3B, supported by Healthcare Business and Social Systems Business revenue growth 3
Healthcare Business revenue rose significantly YoY on blood pressure monitor demand recovery in Europe; Social Systems Business revenue rose significantly YoY on expanding renewable energy demand 3
Gross margin improved 0.9pp YoY driven by price optimization and cost reduction initiatives 3
Full-year revenue 876,082M JPY (+14.9% YoY), record high; IAB at record 485,738M (+16.2%), SSB +22.2%, DMB +14.7%, HCB +6.9%, all four segments expanded 2
FY2024 guidance issued: revenue 890B JPY, operating income 102B JPY; management projects a third consecutive year of revenue and profit growth 2
FY2023 strategy defined as transformation acceleration with five priority initiatives; capital expenditure rose 31.8% to 45.0B JPY with 54.0B JPY planned for FY2024 2
OMRON Business Model
How OMRON (6645.T) makes its money, summarised from the filings up to Q1 FY2027, neutral and without forecast. NadirAlpha methodology
Omron Corporation is a Japanese industrial electronics and automation company whose revenue is generated primarily across three continuing business segments: Industrial Automation (IAB: control components, robots, and sensing systems for manufacturing), Healthcare (blood pressure monitors and connected medical devices sold B2B and B2C), and Social Systems (traffic management, energy storage, and environmental sensing infrastructure). The Device & Module Solutions segment (electronic components) is classified as a discontinued operation pending its planned divestiture to The Carlyle Group, with execution scheduled for October 1, 2026. The IAB segment is the largest revenue contributor and the primary driver of cyclical earnings, with structural exposure to global manufacturing capex cycles and, increasingly, AI-driven semiconductor fabrication and data center automation demand. Under its SF 2nd Stage strategy (FY2026-FY2030), Omron is pivoting toward GEMBA DX (the digital transformation of factory floors) by integrating its hardware device portfolio with emerging data service businesses. The Healthcare segment extends its reach through the OMRON connect health management platform, deployed in over 130 countries with more than 15 million cumulative downloads, and through the Luscii Healthtech remote diagnostics subsidiary acquired in April 2024. Omron adopted IFRS beginning with the fiscal year ending March 2027. Portfolio rationalization, including the DMB divestiture and the November 2025 auto electronics exit, reflects a strategic focus on higher-margin, data-enabled industrial and healthcare automation businesses.
OMRON Stock: Share-Price Drivers
The drivers of OMRON stock from the company's perspective: demand, prices, costs and capacity as the investor relations reports describe them. NadirAlpha methodology
IAB is by far the largest segment at JPY 209,864 million total group revenue, with segment sales of 131,194 million yen and stated growth of 37.2% in 2027-Q1, so swings in control-equipment demand dominate group revenue and the raised guidance 11
Largest segment, 2027-Q1 revenue 131,194 million yen with stated growth of 37.2%; growth flagged as accelerating and group operating income reached JPY 18,857 million 11
2027-Q1 segment revenue 36,432 million yen with stated growth of 16.7%; traction supported by the Intellisence AFib blood-pressure monitor rollout and the OMRON connect app across 130-plus countries 11 10
2027-Q1 segment revenue 13,065 million yen with stated growth of 22.8%, built on the JMDC acquisition and the data-solutions unit established in 2023 11 8
2027-Q1 segment revenue 24,249 million yen with stated growth of -2.0%, the only segment contracting in the quarter 11
Planned transfer of the Device & Module Solutions business to Carlyle Group effective 2026-10-01, alongside the Matsuya R&D acquisition completed 2026-06-19; reshapes future segment mix 11 10
Sector trend: Core KPIs are improving: control-equipment demand is recovering and group profitability turned up, with net income of JPY 10,635 million in 2027-Q1 and guidance raised. Healthcare and data-solutions demand is expanding while social-systems demand is broadly flat to slightly lower 11.
OMRON Revenue by Type (as of 2027-Q1 · JPY million · 7/17)
Where the revenue of OMRON comes from: segments and product types with share, growth and margin, as of Q1 FY2027, older structures remain in the expandable part. NadirAlpha methodology
| Segment | Since | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|
| Period 2027-Q1 (3M) | |||||
| DSB (Data Solution Business) | 2024-Q3 | 13,065 | 22.8% | – | 11 |
| IAB (Control Components Business) (industrial control devices unit) | 2023-Q3 | 131,194 | 37.2% | – | 11 |
| HCB (Healthcare Business) | 2023-Q3 | 36,432 | 16.7% | – | 11 |
| SSB (Social Systems Business) (public/social infrastructure unit) | 2023-Q3 | 24,249 | -2% | – | 11 |
| Period FY2026 (12M) | |||||
| Data Solution Business | FY2026 | 512 | 23% | 7.1% | 10 |
| Period FY2026 | |||||
| Social Systems Solutions & Services Business | – | – | – | – | 10 |
| Period 2026-H1 (6M) | |||||
| DMB | 2023-Q3 | 56,625 | – | – | 9 |
| Period FY2025 (12M) | |||||
| Data Solution Business | FY2025 | 3,870 | – | – | 8 |
| Device & Module Solutions Business | FY2023 | 6,754 | 11.2% | – | 8 |
| Industrial Automation Business | FY2023 | 6,057 | 16.5% | – | 8 |
| Healthcare Business | FY2023 | 5,144 | 30.3% | – | 8 |
| Social Systems Solutions & Services Business | FY2023 | 4,693 | 15.6% | – | 8 |
| Period FY2024 | |||||
| Device & Module Solutions Business | – | – | – | – | 6 |
| Healthcare Business | – | – | – | – | 6 |
| Control Components Business (industrial control devices segment) | – | – | – | – | 6 |
| Social Systems Business (public/social infrastructure segment) | – | – | – | – | 6 |
| Electronic Components Business | – | – | – | – | 6 |
OMRON Products & announcements (1/19 active+recent)
What OMRON launched, had approved or announced, from the filings up to Q1 FY2027, each row with the date of first mention. NadirAlpha methodology
Status: PlannedLaunchedStable
| Product/Line | Since | Status | Source |
|---|---|---|---|
| 2026 | |||
| SF 2nd Stage Launch (second phase of SF initiative) | 2026-04 | 10 | |
| 2025 | |||
| Omron Software Co., Ltd. renamed to Omron Digital Co., Ltd. (subsidiary name change) | 2025-10 | 10 | |
| Power Electronics Center Established (new power electronics facility) | 2025 | 10 | |
| Digital Twin Technology Collaboration with NVIDIA | 2025 | 10 | |
| Strategic Partnership with Cognizant | 2025 | 10 | |
| 2024 | |||
| G9KB-E (High-Capacity Power Relay) | 2024-06 | 8 | |
| NEXT2025 Structural Reform Program | 2024-04 | 8 | |
| Soratena Pro (Compact Weather IoT Sensor) | 2024 | 6 | |
| V2X System | 2024 | 6 | |
| Launch of Intellisense AFib Blood Pressure Monitor | 2024 | 10 | |
| 2023 | |||
| Establishment of Data Solution Business Division | 2023-12 | 6 | |
| Establishment of Data Solution Business Division | 2023-12 | 5 | |
| Establishment of Health Management Alliance | 2023-06 | 5 | |
| Establishment of Health Management Alliance | 2023-06 | 6 | |
| Omron Corporation | 2023-03 | 2 | |
| Generative AI Project AIZAQ | 2023 | 6 | |
| Data Solution Business Division | 2023 | 6 | |
| Women Leaders Circle | 2023 | 6 | |
| 2016 | |||
| OMRON connect Health Management App Rollout (2×) | 2016 | 5 | |
OMRON Transactions & Events (17)
Transactions of OMRON since 2024: acquisitions, disposals, agreements and regulation, deliberately including smaller items; purchase prices only when the company names them. NadirAlpha methodology
Acquisitions by OMRON
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2026 | |||
| Acquisition of Matsuya R&D Co. | 2026-06 | Completed | 10 |
| Share Acquisition of Matsuya R&D via Tender Offer | 2026 | Completed | 10 |
| 2024 | |||
| Full Subsidiarization of Luscii Healthtech B.V. | 2024-04 | Completed | 10 |
| Subsidiarization of CancerScan Co. | 2024-01 | Completed | 6 |
| Share Acquisition of CancerScan Co., Ltd. | 2024-01 | Completed | 5 |
| CancerScan Subsidiarization | 2024-01 | Completed | 8 |
| 2023 | |||
| Acquisition of JMDC Co. | 2023-09 | Completed | 8 |
| Investment in Omron Kirin Techno Systems Co., Ltd. | 2023-04 | Completed | 2 |
| Establishment of Omron Expert Engineering Co., Ltd. | 2023-04 | Completed | 6 |
| Subsidiarization of Omron Kirin Techno System Co., Ltd. (inspection equipment manufacturer for beverage industry) | 2023 | Completed | 6 |
Divestitures and exits by OMRON
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2026 | |||
| Transfer of Device & Module Solutions Business (Electronic Components Business) | 2026-10 | Divested | 10 |
| Transfer of Device & Module Solutions Business to Carlyle Group | 2026-10 | Divested | 11 |
| Absorption-Type Company Split of DMB Business | 2026-07 | Divested | 10 |
| 2025 | |||
| Transfer of OMRON AUTOMOTIVE ELECTRONICS ITALY S.R.L. (2x) | 2025-07 | Divested | 10 |
| 2024 | |||
| Delisting of Depositary Receipts on Frankfurt Stock Exchange | 2024-09 | Divested | 5 |
| 2023 | |||
| Suspension of Russia Business | 2023-09 | Divested | 5 |
| 2022 | |||
| Indefinite Suspension of Control Equipment Business and Electronic Components Business in Russia | 2022-08 | Divested | 2 |
OMRON Risks (46 since the annual report of 2026-06-22, 107 tracked in total)
NadirAlpha lists 46 active risks of OMRON from the filings, the category as a coloured dot with legend, the wording as a short summary of the filing with no assessment of our own. NadirAlpha methodology
Category: MarketRegulatoryPeopleCyberFinancialGeopoliticsCustomersSupply chainLegalTechnologyCompetition品質Macromarketing
| Risk | Category | Last reported |
|---|---|---|
| OMRON: first mention in Quarterly report (EDINET) of 2026-08-05 (2027-Q1), source 11 | ||
| 第2四半期以降の事業環境はSocial Systems Businessにおける競争環境が期初想定より厳しくなると見ている | = | |
| 2027年3月期より国際財務報告基準(IFRS)を適用している | = | |
| OMRON: first mention in Annual report (EDINET) of 2023-06-23 (FY2023), source 2 | ||
| AI需要の拡大による半導体業界の設備投資が市場を牽引する可能性がある | 2027-Q1 2026-08-05 11 | |
| OMRON: first mention in Annual report (EDINET) of 2026-06-22 (FY2026), source 10 | ||
| 大規模なシステム障害 | = | |
| サイバー攻撃または個人・技術情報管理不全による情報漏洩、事業停止 | = | |
| 市況悪化やシステム投資効果不十分による資産貸倒・評価額下落 | = | |
| 米国関税引上げ、中国レアアース輸出管理強化による競争力低下 | = | |
| 紛争発生に伴う製品供給停止・大幅コスト増加 | = | |
| 海外投資規制による買収・出資審査の想定外長期化 | = | |
| サプライチェーン上の人権課題発生 | = | |
| 自社工場の生産停止 | = | |
| 重要仕入先からの長期にわたる部品供給停止 | = | |
| Board focus on CEO succession planning and emergency succession plans for mid-Stage roadmap execution | = | |
| ハラスメント・労働基準違反・労働安全衛生問題 | = | |
| 社内不正や会計基準非準拠の不適切な会計処理 | = | |
| 輸出規制や制裁違反 | = | |
| 事業撤退に伴う多額費用計上・法規制違反・訴訟 | = | |
| 新規事業における業法違反、許認可取得に関する不備 | = | |
| 関税法・移転価格税制等の法規制違反 | = | |
| 接待・贈答等の贈収賄に関する法規制違反 | = | |
| 各国データ・プライバシー規制違反 | = | |
| Female managers represent 13.4% of management positions; wage gap for regular employees at 75.1% | = | |
| 環境に関する新たな取引・開示規制違反・対応コスト増加 | = | |
| 当社グループの技術・ノウハウ流出またはブランド模倣 | = | |
| 特許等の侵害または不正使用に関する紛争 | = | |
| 事業戦略と連動した技術開発・知財活用の不足による競争力喪失 | = | |
| 競争法・取適法等の公正な取引に関する法規制違反 | = | |
| 製品セキュリティ脆弱性に対するサイバー攻撃によるネットワーク稼働停止 | = | |
| 大規模リコール発生、製品環境・安全・セキュリティ関連法規制違反 | = | |
| 配当可能額は93,760百万円で、配当支払後の純資産は3百万円を下回ることはできない | = | |
| 繰越欠損金は日本では86,084百万円、海外では17,340百万円で、大部分は控除期限が到来する | = | |
| 米国関税政策による影響がある | = | |
| 原材料価格の高騰と物流コスト上昇の影響 | = | |
| 半導体等重要部品の供給逼迫拡大 | = | |
| 巨大地震・洪水豪雨等の自然災害による事業影響 | = | |
| 販促活動でのグリーンウォッシングと捉えられる不適切表示 | = | |
| 中東情勢の動向次第で世界経済が大きな影響を受ける可能性がある | = | |
| 従業員エンゲージメント低下・労務トラブル発生 | = | |
| 先端技術保有人財の獲得競争激化による獲得失敗 | = | |
| 通常の事業活動から生じるいくつかの法的な申立ておよび訴訟を受けているが、重要な影響はない | = | |
| 2026年度より国際財務報告基準(IFRS)を任意適用することによる影響 | = | |
| 血圧計のグローバルでの主要価格帯における競争激化 | = | |
| OMRON: first mention in Annual report (EDINET) of 2025-06-23 (FY2025), source 8 | ||
| JMDC社との資本業務提携にかかる契約上の規定 | FY2026 2026-06-22 10 | |
| EV関連分野の設備投資が停滞している状況 | FY2026 2026-06-22 10 | |
| OMRON: first mention in Annual report (EDINET) of 2024-06-21 (FY2024), source 6 | ||
| ITインフラ等の大規模停止 | FY2026 2026-06-22 10 | |
| OMRON: first mention in Annual report (EDINET) of 2023-06-23 (FY2023), source 2 | ||
| M&A投資先の業績悪化・想定シナジー未発揮・コンプライアンス問題 | FY2026 2026-06-22 10 | |
OMRON Reported KPIs (as disclosed) (7)
Figures OMRON discloses itself in addition to the standard financials, such as order intake, recurring revenue or unit counts, as reported and with no calculation of our own. NadirAlpha methodology
| KPI | Value / change | Source |
|---|---|---|
| OMRON, published 2026-06-22, period FY2026 | ||
| Shareholders Equity Ratio | 55.1% | 10 |
| Female Managers Ratio Omron | 13.4 | 10 |
| ROIC Guidance | Approx. 4.0% | 10 |
| ROIC | 3.9% | 10 |
| ROE Guidance | Approx. 5.5% | 10 |
| ROE | 4.7% | 10 |
| OMRON, published 2024-11-14, period 2025-H1 | ||
| Equity Ratio | 56.6 | 7 |
OMRON Development
The business development of OMRON period by period up to Q1 FY2027, each text from the original report of that period, source numbers lead to the source. NadirAlpha methodology
FY2027: OMRON
In the first quarter of fiscal year 2027, Omron reported revenue of JPY 209,864 million and operating income of JPY 18,857 million, representing year-on-year increases of 26.1% and 226.0% respectively 11. Growth in the Control Devices segment was driven by AI-related semiconductor investment and secondary battery investments destined for data centers 11. The Healthcare segment's blood pressure monitor business outperformed the prior year supported by online promotional initiatives in Japan and Asia, and the Data Solutions segment expanded on a favorable business environment 11. Following this performance, Omron raised its full-year consolidated forecast for revenue, operating income, and pre-tax income 11, and announced the planned divestiture of its Device & Module Solutions (electronic components) business to Carlyle Group with an expected effective date of October 1, 2026 11.
FY2026: OMRON
Omron Corporation reported FY2026 consolidated revenue of 767,351 million yen, an increase of 7.3% year-over-year, driven by recovery in the Industrial Automation (Control Components Business) and Electronic Components (Electronic Components Business) segments on semiconductor and generative AI-related demand 10. Full-year net income attributable to shareholders reached 28,487 million yen, up 75.1% against the prior fiscal year, which had been burdened by net losses of approximately 37,109 million yen stemming from NEXT2025 restructuring charges and impairments 10. The NEXT2025 structural reform program was completed during FY2026, with the Industrial Automation (Control Components Business) segment recording revenue growth of 12.3% and operating profit growth of 18.0%, while selling, general and administrative expense ratio improved to 31.9% from 33.1% in the prior year 10. A major portfolio decision was made to classify the Device & Module Solutions Business (Electronic Components Business, DMB) as a discontinued operation, with its transfer to The Carlyle Group planned for October 1, 2026 10. Omron launched its SF 2nd Stage strategic plan covering FY2026 through FY2030, targeting transformation toward GEMBA DX with concentrated investment across eight device businesses and five data service businesses, and cumulative cash generation of 1,050 billion yen over the five-year period 10.
FY2025: OMRON
In FY2025, Omron Corporation reported revenue of 715,379 million JPY (110), declining from 818,761 million JPY in the prior year (8), as demand weakness in the Industrial Automation Business and Device & Module Business persisted throughout the year. The first half saw revenue fall 6.5% year-over-year to 374,638 million JPY, while gross margin improved from 42.9% to 45.4% (7), reflecting a mix shift and cost measures under the NEXT2025 structural reform program. Omron recognized cumulative restructuring charges of 27,781 million JPY in FY2025 under NEXT2025, targeting workforce optimization, facility consolidation, and an IAB revival plan, alongside an 11,725 million JPY goodwill impairment on the Data Solutions Business segment stemming from a decline in JMDC's share price (8). Net income attributable to shareholders recovered to 16,271 million JPY from 8,105 million JPY in the prior year (8), supported by an increase in operating cash flow to 55,784 million JPY from 44,875 million JPY and a free cash flow turn to positive at approximately 7,900 million JPY (8). The period also marked the full consolidation of JMDC and its 35 subsidiaries into the newly established Data Solutions Business reporting segment (8).
FY2024: OMRON
In FY2024 (April 2023–March 2024), Omron's consolidated revenue declined to JPY 818,761M from JPY 876,082M in the prior year, as prolonged weakness in global manufacturing capital expenditure demand weighed heavily on the Industrial Automation Business (IAB) and Electronic Components Business (ECB) throughout most of the year 6. Net income attributable to shareholders fell sharply to JPY 8,105M (EPS: JPY 41.17) from JPY 73,861M (EPS: JPY 372.19) in the prior year, with the decline amplified by equity revaluation losses totaling approximately JPY 22.0B recognized in connection with the consolidation of JMDC 5 6. Healthcare Business revenues expanded on recovery of blood pressure monitor demand in Europe, and Social Systems Business grew on renewable energy and railway infrastructure demand, partially offsetting declines in other segments 3 6. In October 2023, Omron consolidated JMDC (medical statistics data services) at approximately 54.3% ownership, established a new Data Solutions Business (DSB) operating segment in December 2023, and expanded the consolidated group from 117 to 156 subsidiaries 5 6. In February 2024, Omron announced the NEXT2025 structural reform program targeting approximately 2,000 global headcount reductions, and withdrew the medium-term plan 'SF 1st Stage,' with the successor plan 'SF 2nd Stage' scheduled for FY2026 to 2030 6.
FY2023: OMRON
In FY2023 (fiscal year ended March 2023), Omron Corp. achieved record full-year revenue of 876,082M JPY, up 14.9% year-over-year, while net income attributable to shareholders rose approximately 20.4% to 73,861M JPY 2. The IAB segment was the primary growth driver, with sales advancing 16.2% to a record 485,738M JPY and operating profit rising 12.6% to a record level; SSB posted the strongest segment revenue growth at +22.2%, DMB expanded 14.7%, and HCB grew 6.9% 2. The HCB segment saw operating profit decline 13.6% for the full year, with global inflation headwinds and retailer closures under China's zero-COVID policy compressing margins despite the revenue increase 2. Full-year operating cash flow of 53,456M JPY fell 20.7% year-over-year despite record profitability, while capital expenditure increased 31.8% to 45.0B JPY as Omron expanded production capacity in line with its mid-term investment plan 2. Management issued FY2024 guidance for revenue of 890B JPY and operating income of 102B JPY, projecting a third consecutive year of revenue and profit growth 2.
Glossary
- Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
- Op. income: The operating line of the income statement; EBIT only as a marked fallback, never pre-tax or ordinary income.
- Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
- EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
- FCF: Free cash flow = operating cash flow minus capital expenditure on property, plant and equipment; the company's own free cash flow figure is shown separately.
- OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
- Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
- Net Debt: Net debt = financial debt excluding lease liabilities minus cash at the same reporting date; the company's own net position may differ.
- *: derived, the formula is in the hover
- ≈: calculated, approximation
- ~: uncertain; the value stays visible, verdicts do not use it
- °: repaired by a targeted query against the document, or curated with documentary evidence
- EBIT: EBIT as a fallback: the income statement carries no operating line
- basic: basic earnings per share as a fallback when diluted is missing
Sources: quarterly reports, annual reports and investor relations documents
All original documents NadirAlpha used for this report on OMRON stock: quarterly and annual reports, earnings releases and investor relations documents, sorted by publication, the document type is the link. Note on EDINET (Japan): direct retrieval via the EDINET API requires a free API key; alternatively all documents are freely available via the EDINET search (disclosure2.edinet-fsa.go.jp). NadirAlpha methodology
| # | Document type | Published |
|---|---|---|
| #1 | Quarterly report (EDINET) | 2023-02-10 |
| #2 / #102 | Annual report (EDINET) | 2023-06-23 |
| #3 / #103 | Quarterly report (EDINET) | 2023-08-09 |
| #4 / #104 | Quarterly report (EDINET) | 2023-11-14 |
| #5 / #105 | Quarterly report (EDINET) | 2024-02-14 |
| #6 / #106 | Annual report (EDINET) | 2024-06-21 |
| #7 / #107 | Half-year report (EDINET) | 2024-11-14 |
| #8 / #108 | Annual report (EDINET) | 2025-06-23 |
| #9 / #109 | Half-year report (EDINET) | 2025-11-14 |
| #10 / #110 | Annual report (EDINET) | 2026-06-22 |
| #11 / #111 | Quarterly report (EDINET) | 2026-08-05 |
OMRON Stock FAQ
Is there a management forecast (guidance) for FY2027?
Yes. Management has issued targets for FY2027, including Revenue. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Where can I find the official investor relations documents of OMRON?
NadirAlpha links all 11 original filings used (EDINET filings) in the sources chapter: quarterly report, annual report, half-year report, each with type, publication date and a direct link; every figure in the report carries a source number.